You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Carboplatin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for carboplatin and what is the scope of patent protection?

Carboplatin is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hikma, Hospira, Natco Pharma Usa, Pliva, Sandoz, Watson Labs Teva, Corden Pharma, Accord Hlthcare, Actavis Totowa, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Meitheal, Norvium Bioscience, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sun Pharm, Teva Parenteral, Teva Pharms Usa, Teyro Labs, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Eleven suppliers are listed for this compound.

Summary for carboplatin
Drug Prices for carboplatin

See drug prices for carboplatin

Recent Clinical Trials for carboplatin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMD SeronoPhase 1
Yale UniversityPhase 1
MSD Italia S.r.l.Phase 2

See all carboplatin clinical trials

Pharmacology for carboplatin
Medical Subject Heading (MeSH) Categories for carboplatin

US Patents and Regulatory Information for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077139-002 Sep 21, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-002 Jul 14, 2003 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Meitheal CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077096-004 Jun 3, 2013 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Totowa CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 078732-001 Feb 6, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 207324-003 Feb 15, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 ⤷  Sign Up ⤷  Sign Up
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-001 Jul 14, 2003 ⤷  Sign Up ⤷  Sign Up
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-002 Jul 14, 2003 ⤷  Sign Up ⤷  Sign Up
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-004 Jan 15, 2004 ⤷  Sign Up ⤷  Sign Up
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-003 Jul 14, 2003 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.